Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double Blind Trial Of Megestrol Acetate Versus Placebo For The Treatment Of Inoperable Hepatocellular Carcinoma

NCT00041275 is registered in ClinicalTrials.gov with National Medical Research Council (NMRC), Singapore as lead sponsor.

NCT NCT00041275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00041275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double Blind Trial Of Megestrol Acetate Versus Placebo For The Treatment Of Inoperable Hepatocellular Carcinoma
Lead sponsor
National Medical Research Council (NMRC), Singapore
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2002
Completion date
August 31, 2011
Enrollment
300 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer